Immunodiagnostic Biomarkers Advance Non-Invasive Cancer Detection
*Corresponding Author: Ming Zhao, Shanghai Oncology & Diagnostics Center, China, Email: ming.zhao@shanghaioncology.cnReceived Date: Nov 01, 2025 / Accepted Date: Dec 01, 2025 / Published Date: Dec 01, 2025
Citation: Zhao M (2025) Immunodiagnostic Biomarkers Advance Non-Invasive Cancer Detection. jcd 09: 325.DOI: 10.4172/2476-2253.1000325
Copyright: © 2025 Ming Zhao This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use,distribution and reproduction in any medium, provided the original author and source are credited.
Abstract
This review synthesizes recent advances in immunodiagnostic biomarkers for various cancers, including hepatocellular carci
noma, colorectal, prostate, breast, non-small cell lung, pancreatic, and gastric cancers. Key biomarkers such as circulating tumor
DNA, microRNAs, exosomes, and circulating tumor cells are highlighted for their potential in early detection, prognosis, and treat
ment monitoring. The collective research emphasizes a shift towards non-invasive diagnostic strategies and personalized medicine,
aiming to improve diagnostic accuracy and patient outcomes across diverse malignancies. Significant progress in liquid biopsy
approaches is transforming cancer diagnostics.
